- The General Rules for the Study of Primary Liver Cancer
-
Jang JY, Lee JS, Kim HJ, Shim JJ, Kim JH, Kim BH, Kwon CH, Lee SD, Lee HW, Kim JH, Jeong WK, Choi JY, Ko HK, Lee DH, Kim H, Kim BH, Yoon SM, Yoon WS, Um SH, 17th Committee for revision of the general rules for primary liver cancer
- KMID: 2376803
- J Liver Cancer.
- 2017 Mar;17(1):19-44.
- doi: 10.17998/jlc.17.1.19
The General Rules for the Study of Primary Liver Cancer was published in June 2001 as the first edition. Since then, the 5th edition of the General Rules for the... -
- CITED
-
- Close
- SHARE
-
- Close
- Animal Models of Liver Cancer: Current Status and Application in Preclinical Research
-
Ju HL, Ro SW
- KMID: 2376801
- J Liver Cancer.
- 2017 Mar;17(1):1-14.
- doi: 10.17998/jlc.17.1.1
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. HCC develops in various causes – Viral hepatitis infection, toxins, or other liver conditions - by activation of oncogenes... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Simultaneous Resection of Recurrent Combined Hepatocellular Cholangiocarcinoma and Hypovascular Hepatocellular Carcinoma
-
Kim TH, Um SH, Park SJ, Park SW, Lee HA, Seo YS, Yu YD, Kim DS, Kim JY
- KMID: 2376811
- J Liver Cancer.
- 2017 Mar;17(1):94-99.
- doi: 10.17998/jlc.17.1.94
Liver cancer is more complex to treat compared to cancers in other organs, since liver function should be considered. In addition, only a few patients can be applied curative treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Combination of Transarterial Chemoebolization and Radiofrequency Ablation for Hepatocellular Carcinoma Treatment
-
Jang BK
- KMID: 2376802
- J Liver Cancer.
- 2017 Mar;17(1):15-18.
- doi: 10.17998/jlc.17.1.15
Recently, various combination therapies have been applied to the treatment of hepatocellular carcinoma (HCC). Among various treatment modalities, transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) were combined to improve the... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of a Patient with Hepatocellular Carcinoma and Lung Metastasis Who Failed Sorafenib Treatment and Achieved Complete Remission after Lung Resection and Radiation Therapy
-
Yu JH, Lee JI
- KMID: 2376808
- J Liver Cancer.
- 2017 Mar;17(1):77-81.
- doi: 10.17998/jlc.17.1.77
In hepatocellular carcinoma (HCC), sorafenib is the only approved systemic chemotherapy, and has been applied for those with advanced HCC especially with systemic metastasis. However, the treatment results are suboptimal... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Advanced Hepatocellular Carcinoma with Long-term Post-progression Survival under Repeated Transarterial Chemoembolization after Sorafenib Failure
-
Lee J, Kim HY, Jung YJ, Kim TH, Yoo K
- KMID: 2376809
- J Liver Cancer.
- 2017 Mar;17(1):82-87.
- doi: 10.17998/jlc.17.1.82
Hepatocellular carcinoma is the third leading cause of cancer related mortality worldwide. Only 30% of patients are eligible for curative surgical resection at diagnosis. For patients with advanced hepatocellular carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Sarcomatoid Cholangiocarcinoma Which Developed at the Site Previously Treated by Transarterial Chemoembolization
-
Lee C, Kang KM, Lee HL, Lee SW, Lee H, Han NI
- KMID: 2376812
- J Liver Cancer.
- 2017 Mar;17(1):100-104.
- doi: 10.17998/jlc.17.1.100
Intrahepatic sarcomatoid carcinoma is a rare tumor with poor prognosis due to its highly invasive and metastatic nature and difficulty for early detection. The most common form of intrahepatic sarcomatoid... -
- CITED
-
- Close
- SHARE
-
- Close
- Selection of Proper Modality in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
-
Choi SH, Woo JY, Seong J
- KMID: 2376804
- J Liver Cancer.
- 2017 Mar;17(1):45-53.
- doi: 10.17998/jlc.17.1.45
BACKGROUND/AIMS: As the optimal stereotactic body radiation therapy (SBRT) modality for hepatocellular carcinoma (HCC) has not been confirmed, we aimed herein to provide a practical guideline by our retrospective review. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Affecting Prognosis of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Implications for Future Therapeutic Strategies
-
Suh SJ, Yim HJ, Lee DW, Hyun JJ, Jung YK, Kim JH, Seo YS, Yeon JE, Byun KS, Um SH
- KMID: 2376806
- J Liver Cancer.
- 2017 Mar;17(1):60-71.
- doi: 10.17998/jlc.17.1.60
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) exhibits poor prognosis. The aim of this study is to evaluate factors associated with survival of HCC patients with PVTT... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Hepatocellular Carcinoma with Pulmonary Metastasis Who Showed Complete Response by Cytotoxic Chemotherapy after Sorafenib Failure
-
Park HS, Jang JY, Baek MY, Kim YK, Youn HJ, Back SY, Jeong SW, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS
- KMID: 2376807
- J Liver Cancer.
- 2017 Mar;17(1):72-76.
- doi: 10.17998/jlc.17.1.72
Hepatocellular carcinoma (HCC) is the 2nd most common cause of cancer related death in Korea and well-known malignancy with poor prognosis. Sorafenib is the first-line molecular targeted agent in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Achieving Complete Remission with Combination of Sorafenib and Tegafur in Patients with Hepatocellular Carcinoma with Progression of Disease after Sorafenib Therapy
-
Hwang SY, Lee SM, Im JW, Jeon KJ, Ahn SB, Park JY, Choi CW, Yang KM
- KMID: 2376810
- J Liver Cancer.
- 2017 Mar;17(1):88-93.
- doi: 10.17998/jlc.17.1.88
Sorafenib is the only approved targeted agent as the first line systemic therapy for treatment of advanced hepatocellular carcinoma (HCC). However, the improvement of survival duration under 3 months is... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of Surgical Resection for Ruptured Hepatocellular Carcinoma
-
Lee HW, Lim CS, Kim HS
- KMID: 2376805
- J Liver Cancer.
- 2017 Mar;17(1):54-59.
- doi: 10.17998/jlc.17.1.54
BACKGROUND/AIMS: Many recent studies have shown excellent outcomes of surgical resection for ruptured hepatocellular carcinoma (HCC). In addition, there are several reports suggesting that a ruptured HCC did not increase... -
- CITED
-
- Close
- SHARE
-
- Close
